Fundai

Darupakhsh Pharmaceutical Chemistry Company (DSHIMI) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DSHIMI
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations-224,3781,375,6821,171,2212,272,169724,222-201,337
Cash payments for income tax-99,092-364,813-960,972-272,024-174,978-118,134
Net cash inflow (outflow) from operating activities-323,4701,010,869210,2492,000,145549,244-319,471
Cash payments for purchase of property, plant and equipment-61,837-32,659-72,944-161,459-21,492-39,804
Cash payments for purchase of intangible assets-39-1,449-659-1,772-162-11,024
Cash receipts from dividends546036,2122442636
Cash receipts from interest on other investments1,0384,946207516815
Net cash inflow (outflow) from investing activities-60,292-29,162-35,796-162,936-21,563-50,777
Net cash inflow (outflow) before financing activities-383,762981,707174,4531,837,209527,681-370,248
Cash receipts from facilities3,933,8821,749,3431,285,0001,643,806579,2122,280,512
Cash payments for principal of loans-1,618,622-2,279,677-957,277-1,713,173-617,233-1,236,594
Cash payments for interest on loans-548,675-372,263-118,560-218,960-136,999-107,481
Cash payments for dividends-932,550-233,118-36,809-860,104-251,542-113,633
Net cash inflow (outflow) from financing activities834,035-1,135,715-39,620-818,385-394,847782,982
Net increase (decrease) in cash450,273-154,008134,8331,018,824132,834412,734
Cash balance at beginning of year310,872756,57893,788467,619158,42250,249
Effect of changes in exchange rates2,737135142-2,172-623129
Cash balance at end of year763,882602,705228,7631,484,271290,633463,112

Reporting periods

71 periods are on file for this report, from the period ending 1387/12/30 to the period ending 1405/06/31.